Therapeutic Asset Ratings
234 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
TAMOXIFEN
Estrogen Receptor Positive Breast Cancer
Dana-Farber Cancer Institute
P4
BBB
(77)
PREDNISONE TABLETS
Metastatic Carcinoma in the Skin
Dana-Farber Cancer Institute
P4
BBB
(73)
LEUPROLIDE
Prostatic Neoplasms
Dana-Farber Cancer Institute
P4
BB
(71)
MERCAPTOPURINE ANHYDROUS
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute
P4
BB
(71)
PEGASPARGASE
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute
P4
BB
(71)
TAMOXIFEN
Estrogen Receptor-positive Breast Cancer
Dana-Farber Cancer Institute
P4
BB
(71)
Docetaxel
Stage IV Breast Cancer
Dana-Farber Cancer Institute
P3
BB
(71)
MERCAPTOPURINE ANHYDROUS
Leukemia
Dana-Farber Cancer Institute
P3
BB
(70)
PEGASPARGASE
Leukemia
Dana-Farber Cancer Institute
P3
BB
(70)
TAMOXIFEN
Breast Cancer
Dana-Farber Cancer Institute
P4
BB
(69)
Inno-206
Leukemia
Dana-Farber Cancer Institute
P3
BB
(69)
Atezolizumab
Advanced Breast Carcinoma
Dana-Farber Cancer Institute
P3
BB
(68)
Cytosin-Arabinosid
Leukemia
Dana-Farber Cancer Institute
P3
BB
(68)
DEXAMETHASONE
Leukemia
Dana-Farber Cancer Institute
P3
BB
(68)
METHOTREXATE
Leukemia
Dana-Farber Cancer Institute
P3
BB
(68)
Ipilimumab
Recurrent Hodgkin Lymphoma
Dana-Farber Cancer Institute
P2
BB
(68)
Evomela
Multiple Myeloma
Dana-Farber Cancer Institute
P4
BB
(67)
PREDNISONE TABLETS
Cutaneous Squamous Cell Carcinoma
Dana-Farber Cancer Institute
P4
BB
(67)
Rapamycin
Skin Cancer
Dana-Farber Cancer Institute
P4
BB
(67)
Tucatinib
Advanced HER2-positive Breast Cancer
Dana-Farber Cancer Institute
P3
BB
(67)
Tucatinib
Hormone Receptor Negative Breast Carcinoma
Dana-Farber Cancer Institute
P3
BB
(67)
(+)-VINCRISTINE
Leukemia
Dana-Farber Cancer Institute
P2/3
BB
(67)
Rapamycin
Cutaneous Squamous Cell Carcinoma
Dana-Farber Cancer Institute
P4
BB
(66)
TRASTUZUMAB
Estrogen Receptor-positive Breast Cancer
Dana-Farber Cancer Institute
P3
BB
(66)
Everolimus
Cutaneous Squamous Cell Carcinoma
Dana-Farber Cancer Institute
P4
BB
(64)
Showing 1 to 25 of 234 assets
Previous
Page 1 of 10
Next